Phase III trial to study familial chylomicronemia syndrome drug initiated
Ionis Pharmaceuticals' Phase III trial to evaluate AKCEA-APOCIII-LRx in patients…
Ionis Pharmaceuticals' Phase III trial to evaluate AKCEA-APOCIII-LRx in patients with familial chylomicronemia syndrome has begun.